A prospective randomised study in limited disease small cell carcinoma—Doxorubicin and vincristine plus either cyclophosphamide or etoposide
- 30 September 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (10) , 1637-1639
- https://doi.org/10.1016/0959-8049(95)00273-l
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase III trial of the Southeastern Cancer Study Group.Journal of Clinical Oncology, 1992
- Prospective study of etoposide scheduling in combination chemotherapy for limited disease small cell lung carcinomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Randomized Trial of Cyclophosphamide, Doxorubicin, and Vincristine Versus Cisplatin and Etoposide Versus Alternation of These Regimens in Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1991
- Phase III chemotherapy trials in small cell lung cancerLung Cancer, 1989
- Small cell carcinoma of the lungCancer Treatment Reviews, 1982
- Small-Cell Carcinoma of the Lung: Combined Chemotherapy and RadiationAnnals of Internal Medicine, 1978